Seguridad de nivolumab en pacientes con carcinoma de células renales metastásico: experiencia española en urología en la práctica clínica real-Reference-Cited by-同舟云学术

Seguridad de nivolumab en pacientes con carcinoma de células renales metastásico: experiencia española en urología en la práctica clínica real

Published:2019-09 Issue:7 Volume:43 Page:364-370
ISSN:0210-4806
Container-title:Actas Urológicas Españolas
language:es
Short-container-title:Actas Urológicas Españolas

Author:

Amores Bermúdez J.,Osman García I.,Unda Urzáiz M.,Jiménez Marrero P.,Ledo Cepero M.J.,Llarena R.,Flores Martín J.,Abad Vivas-Pérez J.I.,Rodrigo Aliaga M.,Juarez Soto A.

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2016

2. Novel immunotherapeutic strategies in development for renal cell carcinoma;Inman;Eur Urol,2013

3. Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy;Bedke;World J Urol,2014

4. Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving nivolumab;McDermott;J Clin Oncol,2015

5. Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial;Motzer;J Clin Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain;Seminars in Oncology;2024-06

2. Renal Adverse Reaction Secondary to Check-point Inhibitors in Metastatic Renal Cancer;Journal of Clinical Nephrology;2024-05-17

3. Real-World Experience with Nivolumab in Metastatic Renal Cell Carcinoma Patients Who Have Progressed on Prior Therapies: A Single-Center Study from India;South Asian Journal of Cancer;2022-02-11

4. Cáncer renal avanzado, perfiles para los nuevos tratamientos;Medicina Clínica Práctica;2022-01

5. Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes;International Journal of Clinical Oncology;2020-05-11